Toosendanin, a novel potent vacuolar-type H(+)-translocating ATPase inhibitor, sensitizes cancer cells to chemotherapy by blocking protective autophagy

por Dong, Yu, Zhu, Guoyuan, Wang, Sheng-Fang, Keon, Kristine A., Rubinstein, John L., Zeng, Si-Xin, Zhang, Shuang, Chen, Qiu-Ling, Fu, Jing, Li, Min, Shen, Han-Ming, Lu, Jin-Jian, Chen, Xiu-Ping, Lu, Jia-Hong
Publicado 2022